Transdermal delivery system for sufentanil

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8252319
APP PUB NO 20080175890A1
SERIAL NO

11888650

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Transdermal delivery systems for administering sufentanil through the skin are provided. The systems contain a sufficient amount of sufentanil to induce and maintain a constant state of analgesia when applied to a subject. The systems are characterized as having one or more features including a high degree of dosage form rate control over flux of sufentanil from the system, a high net flux of sufentanil from the system through the skin, lack of a permeation enhancer, an adhesive member demonstrating superior shear time, a low coefficient of variation in the net flux of sufentanil from the system, a high delivery efficiency, and a substantially constant steady state net flux of sufentanil from the system. Methods of using the transdermal delivery systems to administer a sufficient amount of sufentanil to induce and maintain analgesia for extended periods when applied to a subject are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DURECT CORPORATION10260 BUBB ROAD CUPERTINO CA 95014

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Theeuwes, Felix Los Altos Hills, US 290 18463
Yum, Su Il Los Altos, US 87 2779

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation